NZ197164A - Antiperspirant composition containing aluminium chloride and aluminium zirconium hydroxychloride - Google Patents

Antiperspirant composition containing aluminium chloride and aluminium zirconium hydroxychloride

Info

Publication number
NZ197164A
NZ197164A NZ197164A NZ19716481A NZ197164A NZ 197164 A NZ197164 A NZ 197164A NZ 197164 A NZ197164 A NZ 197164A NZ 19716481 A NZ19716481 A NZ 19716481A NZ 197164 A NZ197164 A NZ 197164A
Authority
NZ
New Zealand
Prior art keywords
composition
composition according
aluminum
weight
antiperspirant
Prior art date
Application number
NZ197164A
Inventor
L Mackles
H H Gary
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NZ197164A publication Critical patent/NZ197164A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28Zirconium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant

Description

New Zealand Paient Spedficaiion for Paient Number 1 97164 197164 Prserity Datcfs): ;.§9..
CotnpSete Specification FiSsd: 7-Ciass: . ubHcatior. Date: ...
Pf\Q. Journal, !Mo: No.: Date: NEW ZEALAND PATENTS ACI, 1953 COMPLETE SPECIFICATION ANTIPERSPIRANT COMPOSITION CONTAINING AS ACTIVE ANTIPERSPIRANT AGENTS AN ALUMINUM CHLORIDE AND AN ALUMINUM ZIRCONIUM KYDROXYCHLORIDE Jf/We, BRISTOL-MYERS COMPANY, a State of Delaware corporation having offices at 345 Park Avenue, New York, New York, United States of America, hereby declare the invention for which }£ / we pray that a patent may be granted to me/us, and the method by which it is to be performed, to be particularly described in and by the following statement:- (followed by la) - la - ANTIPERSPIRANT COMPOSITION CONTAINING AS ACTIVE ANTIPERSPIRANT AGENTS AN ALUMINUM CHLORIDE AND AN ALUMINUM ZIRCONIUM HYDROXYCHLORIDS This invention relates to novel antiperspirant compositions. More particularly, it concerns antiperspirant compositions containing as active ingredients a combination of an aluminum chloride and an aluminum zirconium hydroxychloride.
It is known in the prior art to use aluminum chloride or aluminum zirconium hydroxychloride individually as antiperspirant materials. We have now found, however, when these materials are employed together they act synergis-tically giving unexpected high activity and response rate.
It is accordingly an object of the present invention to provide a high performance antiperspirant composition containing a carrier and as active antiperspirant material a combination of an aluminum chloride and an aluminum zirconium hydroxychloride.
Other and more detailed objects of this invention will be apparent from the following description and claims.
Unless otherwise indicated the percentages are given in percent by weight based on the total weight of the composition .
It is known that certain types of people will respond to particular types of antiperspirant salts; it being unusual to find more than 60-70% of an antiperspirant panel responding to any one given material. However, when the combination of active ingredients of this invention was used over 93% of the panel participants responded favorably. Additionally, 197164 surprisingly high activities were recorded; 88% had superior activity. It has always been believed that the activity mechanism for different salts differ. What has been discovered here is a combination product that allows activity 5 responses from more than one mechanism.
Normally speaking, one would have expected this combination to be very irritating, since the pH of this solution is very acidic. We have also found that raising the pH alone is not enough to alleviate the irritation response. 10 However, we have also discovered that the use of divalent oxides or hydroxides in combination with small amounts of glycine solve this problem. The alkali earth metal salts or glycine alone can improve the irritation potential problem somewhat, however, it can be essentially eliminated 15 completely with the combination of the divalent metal oxides or hydroxides and glycine used in line with the instant discovery.
The quantity of the aluminum chloride that may be contained in the compositions of the present invention may 20 vary somewhat. For the most part, they will constitute between substantially 5 and substantially 25% by weight based on the total weight of the composition and preferably 7.5% to about 15% by weight. As used herein, the term "an aluminum chloride" is intended to refer to anhydrous aluminum chloride as well 25 as its hydrated and hydroxide forms e.g. AlCl^ • 6^0 or Al2(OH) CI.
The aluminum zirconium hydroxychlorides that are employed in the present invention are well known in the prior art and be described by the general formula: Al . Z 0 (OH) . . CI x H_0 4 n 14-n n 2 wherein n has the value 0 to 14 and x has the value of from 0 to 20. By way of example, mention may be made of compounds PATENT OFRCf 18 MAR 1983 PECEIVEO i n. 197164 of formulas: Al4 ZrO (OH)X1 Cl3 ; and Al ZrO (OH)Cl^ and their corresponding hydrates.
The amount of the aluminum zirconiiam hydroxychloride that may be contained in the composition of this invention may also vary somewhat. Usually, however, it will comprise between -substantially 2% to substantially 20% by weight based on the total weight of the composition and preferably between about 5% to about 10%.
An important feature of the present compositions is the ratio of the aluminum salt and the and the aluminum zirconium salt that they contain-. Thi"5 ratio■ will—be--in—the range of from substantially 0.5 to substantially 2; the preferred range being from about 1.2 5 to about 1.75.
Another important relationship in the present compositions is the aluminum plus zirconium metal:chloride mole ratio. It is important that this be less than .9 to retain the ionic character of the complex which is related to its antiperspirant activity.
As indicated previously, it is highly advantageous to use a combination of magnesium hydroxide (or oxide) and glycine to adjust the pH of our compositions. This combination will ordinarily be used to adjust the pH in the range of from about 2.5 to about 4.5. The glycine will be employed at a level of from substantially 0.25% to substantially 5% by weight based on the total weight of the composition; whereas, the magnesium hydroxide (or-oxide) will constitute substantially 1% to substantially 9%. The ratio of glycine to magnesium hydroxide (or oxide) is also an important factor. This ratio may be in the range of from.about .025 to about 5 but we prefer to employ a ratio in the range of from about 0.1 to about 1.0.
The novel combination of antiperspirant materials and the pH adjusting agents described above may be incorporated 'v;^A'f£MT omci 18 MAR J983 in any of a variety of dosage forms useful for delivering the antiperspirant material. They may be incorporated in a lotion, in a cream or gel, in a foam system, in an aerosol dispensing system, in a pump spray system, as part of an antiperspirant stick or may be delivered in the form of a solution in a suitable solvent vehicle. The following are illustrations of types of formulas in which the present compositions may be employed as active antiperspirant materials: A. Roll-On (Lotions and Creams) Actives 25% Emollients 2-4% Surface active agents 2-4% Buffering systems 2-7% Water q.s. 100% B. Suspension-Anhydrous can be used in the formulation of Aerosols and Aerosol Foams Actives % Emollients -15% Suspending agents 2-5% Buffering agents 2-4% Water q.s. 100% Aerosol Above 70-85% Propellant 15-30% Sticks Actives % Gelling agent ro 1 Waxes -20% Emollients -20% Buffering agents ro • •£» Of Externalphase q.s. 100% * Anhydrous solvent The following Examples are given to further illustrate the present invention. It is understood, however, that the invention is not limited thereto.
EXAMPLE 1 Roll-On Lotion (Emulsion o/w) % by Wt.
AlCl . 6H20 15.00 Mg(OH)~ 3.75 1 Al/Zr trichlorohydrate 10.00 Brij 72 (Polyoxyethylene 2 Stearyl Ether) 3.00 Brij 78 (Polyoxyethylene Stearyl Ether) 1.00 Glycine 0.50 Disodium EDTA 0.10 Polyoxypropylene 15 Stearyl Ether (Arlamol E) 4.00 H20 62.65 100.00 EXAMPLE 2 Clear Water Solution (Pump Spray) A1C13 . 6H20 15.00 Mg(OH)2 3.75 Glycine 0.50 Al/Zr trichlorohydrate^" 10.00 H20 65.75 Proce.tyl AWS (PPG-5 Cetheth 20) 5.00 100.00 EXAMPLE 3 Aerosol Antiperspirant Al/Complex Powder2 6.00 Al/Zr trichlorohydrate"^ 4.00 Dibutyl phthalate 11.00 Al4ZrO(OH)11Cl3 Product prepared by spray drying A1C1-; M (OH)_ and glycine in the weight ratio of 4:1: .5 ^ EXAMPLE 3 (Cont'd) Cabosil M-5 0.30 Bentone 34 0.10 Isobutane 78.60 100.00 EXAMPLE 4 Stick Antiperspirant Al/Complex Powder 15.00 Al/Zr trichlorohydrate 10.00 Stearyl alcohol 20.00 Dibutyl phthalate 41.00 Procetyl AWS (PPG-5 Cetheth 20) 10.00 Montan wax 4.00 100.00 To demonstrate the fact that the combination of the aluminum chloride and the aluminum zirconiiam hydroxychloride act synergistically as antiperspirants, three compositions were prepared identified as Compositions A, B and C which were the same in all respects excepting the active antiperspirant material. Composition A contained 25% by weight of aluminum zirconium hydroxychloride; Composition B contained 10% by weight of aluminum zirconiiam hydroxychloride and 15% by weight of aluminum chloride; and Composition C contained 25% by weight of aluminum chloride. Each of these compositions were tested for antiperspirant activity on a group of individuals that served as an antiperspirant panel. The procedure employed was as described in Federal Register, Vol. 43, Number 196, October 10, 1978 and is called the Gravemetric Axillary Antiperspirant Test.
The results of this test are summarized in Table I below which gives the formulas of Compositions A, B and C O c77 ^ ^ £■' I \. as well as the antiperspirant activity measured for each composition.
TABLE I B Aluminum Zirconium hydroxide Complex 25 10 — Aluminum Chloride — 15 25 Emollient 2-4 2-4 2-4 Surface Active Agents 2-4 2-4 2-4 q.s. buffer to pH 3.2 + .3 q.s. water to 100% pH at time of test 3.5 3.2 3.4 Activity 50% 62% 53% As will be seen from the above Table, a 20-25% enhancement of antiperspirant activity is obtained with a combination of aluminum chloride and aluminum zirconium hydroxychloride as compared with the use of aluminum chloride or aluminum zirconium hydroxychloride.
Although the invention has been described with reference to specific forms thereof, it will be understood that many changes and modifications may be made without departing from the spirit of this invention. 197164

Claims (11)

WHAT WE CLAIM IS:
1. An antiperspirant composition comprising a carrier and as active antiperspirant material a combination of an aluminum chloride and an aluminum zirconium hydroxychloride, said composition comprising, based on the total weight of the composition, from substantially 5% to substantially 25% by weight of an aluminum chloride and from substantially 2% to substantially 20% by weight of an aluminum zirconium hydroxychloride; the ratio of aluminum salt to aluminum zirconium salt in said composition being in the range of from substantially 0.5 to substantially 2 and the mole ratio of aluminium plus zirconium metal to chloride being less than .9.
2. A composition according to Claim 1 including as a pH adjusting agent a combination of magnesium hydroxide or oxide and glycine, said magnesium hydroxide or oxide constituting from substantially 1% to substantially 9% by weight of said composition and said glycine constituting from substantially 0.25% to substantially 5% by weight of said composition.
3. A composition according to Claim 1 or Claim 2 in the form of a lotion.
4. A composition according to Claim 1 or Claim 2 in the form of a solution.
5. A composition according to Claim 1 or Claim 2 in the form of a stick.
6. A composition according to Claim 1 or Claim 2 in the form of an aerosol < composition.
7. A composition according to Claim 1 or Claim 2 in the form of a pump spray composition.
8. A composition according' to Claim 1 or Claim 2 in the form of a cream or a gel. 9 . A composition according to Claim 1 or Claim 2 in the form of a foam. 'i.Z P'ATcOT OFFICB 18 MAR 1983 I
9 - 197164
10. A composition according to Claim 2, whenever formulated in accordance with the formula A, B or C hereinbefore described.
11. A composition according to Claim 1 or Claim 2, substantially as hereinbefore described with particular reference to any one of the foregoing Examples. DATED THIS DAY OF 19-PZ/ A. J. PARK & SON PE.l $ ~S- AGENTS FOR THE APPLICANTS
NZ197164A 1980-05-27 1981-05-21 Antiperspirant composition containing aluminium chloride and aluminium zirconium hydroxychloride NZ197164A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15311380A 1980-05-27 1980-05-27

Publications (1)

Publication Number Publication Date
NZ197164A true NZ197164A (en) 1984-08-24

Family

ID=22545825

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ197164A NZ197164A (en) 1980-05-27 1981-05-21 Antiperspirant composition containing aluminium chloride and aluminium zirconium hydroxychloride

Country Status (17)

Country Link
JP (1) JPS5711908A (en)
AU (1) AU547530B2 (en)
BE (1) BE888975A (en)
CA (1) CA1140470A (en)
CH (1) CH644755A5 (en)
DE (1) DE3120742A1 (en)
FR (1) FR2483230A1 (en)
GB (1) GB2076289B (en)
GR (1) GR75643B (en)
IT (1) IT1170993B (en)
MX (1) MX156358A (en)
NL (1) NL8102540A (en)
NZ (1) NZ197164A (en)
PH (1) PH16329A (en)
PT (1) PT73090B (en)
SE (1) SE452107B (en)
ZA (1) ZA813484B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1153313A (en) * 1980-12-15 1983-09-06 Chung T. Shin Antiperspirant composition containing aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex and method of use
US4774079A (en) * 1980-12-15 1988-09-27 Bristol-Myers Company Antiperspirant composition containing aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex and method of use
US4606915A (en) * 1981-04-23 1986-08-19 Bristol-Myers Company Antiperspirant combination containing an aluminum halohydrate and a stannic halide
US4775528A (en) * 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5114705A (en) * 1983-08-16 1992-05-19 The Gillette Company Antiperspirant composition
US5589196A (en) * 1983-08-16 1996-12-31 The Gillette Company Antiperspirant composition
GB2144992A (en) * 1983-08-16 1985-03-20 Gillette Co Antiperspirants
US4673570A (en) * 1985-03-20 1987-06-16 Carter-Wallace, Inc. Gelled antiperspirant compositions
JPH05112440A (en) * 1991-08-09 1993-05-07 Sayuri Takemoto Coating agent for deodorization
US6136302A (en) * 1999-02-18 2000-10-24 The Procter & Gamble Company Process of making zirconium-aluminum antiperspirant active
US6375937B1 (en) 2000-10-20 2002-04-23 Colgate-Palmolive Company Antiperspirant salts for enhanced cosmetic products
FR2828646B1 (en) 2001-08-17 2004-11-26 Oreal ANHYDROUS ANTITRANSPIRANT STICK
US20040109833A1 (en) 2002-12-09 2004-06-10 Xiaozhong Tang High efficacy, low irritation aluminum salts and related products
US7905673B2 (en) 2003-11-17 2011-03-15 The Procter & Gamble Company Antiperspirant composition and applicator therefor
CA2785448C (en) * 2009-12-23 2014-10-14 Colgate-Palmolive Company Method of making an anhydrous liquid antiperspirant composition
BR112016010562B1 (en) * 2013-11-18 2019-12-31 Colgate Palmolive Co aqueous composition and use of disodium edta as a preservative in an antiperspirant composition
BR112017010098B1 (en) 2014-12-15 2020-12-29 Unilever Nv antiperspirant composition
US9572758B2 (en) 2015-06-30 2017-02-21 Gulbrandsen Technologies, Inc. Method of making high performance activated aluminum sesquichlorohydrate powders
BR102016026099B1 (en) * 2015-11-09 2021-09-28 Gulbrandsen Technologies, Inc ACTIVE ANTI-TRANSPIRING SOLUTION, TOPIC COMPOSITION, AND, METHOD TO REDUCE HUMAN SKIN TRANSPIRATION AND PROVIDE ANTI-BACTERIAL ACTIVITIES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2906668A (en) * 1955-06-13 1959-09-29 Reheis Company Inc Zirconyl and aluminum halohydroxy complex
US3903258A (en) * 1973-08-06 1975-09-02 Gillette Co Zirconium aluminum complexes and method of making the same
US3981986A (en) * 1973-11-23 1976-09-21 Armour Pharmaceutical Company Zirconium-aluminum-polyol buffered anti-perspirant complexes
US4017599A (en) * 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
AU8303275A (en) * 1974-07-17 1977-01-20 Armour Pharma Aluminum-zirconium antiperspirant systems with trace amounts of alkaline earth metals
JPS5454863A (en) * 1977-10-03 1979-05-01 Kubota Ltd Stalk and straw conveying apparatus with safety cover

Also Published As

Publication number Publication date
MX156358A (en) 1988-08-12
JPS5711908A (en) 1982-01-21
FR2483230A1 (en) 1981-12-04
PT73090A (en) 1981-06-01
PT73090B (en) 1983-02-08
GR75643B (en) 1984-08-02
CA1140470A (en) 1983-02-01
DE3120742C2 (en) 1988-10-27
JPS6412245B2 (en) 1989-02-28
NL8102540A (en) 1981-12-16
DE3120742A1 (en) 1982-03-18
SE8103369L (en) 1981-11-28
FR2483230B1 (en) 1985-01-04
SE452107B (en) 1987-11-16
GB2076289A (en) 1981-12-02
IT8148527A0 (en) 1981-05-25
PH16329A (en) 1983-09-05
IT1170993B (en) 1987-06-03
BE888975A (en) 1981-11-26
GB2076289B (en) 1985-01-09
CH644755A5 (en) 1984-08-31
ZA813484B (en) 1982-05-26
AU7092881A (en) 1981-12-03
AU547530B2 (en) 1985-10-24

Similar Documents

Publication Publication Date Title
NZ197164A (en) Antiperspirant composition containing aluminium chloride and aluminium zirconium hydroxychloride
US4937069A (en) Anhydrous semi-solid antiperspirant suspension
CA1172572A (en) Antiperspirant composition
US4053581A (en) Antiperspirant solution containing a mixture of substantially volatile and substantially non-volatile siloxane liquids
US4073880A (en) Antiperspirant solution containing a substantially volatile polydimethyl siloxane liquid
EP3223914B1 (en) Zinc phosphate complex
JP2004500306A (en) Underarm cosmetic composition containing lower alkyl acetate
US20060067901A1 (en) Antiperspirant compositions
US4215105A (en) Anticalculus oral composition
WO2019206764A1 (en) An antiperspirant composition
EP3586925B1 (en) Zinc phosphate complex
EP3233207B1 (en) Personal care compositions with zinc phosphate active
AU2022287610A1 (en) An antiperspirant composition
US20220257480A1 (en) An antiperspirant composition
US5135741A (en) Antiperspirant product
EP3941594B1 (en) An antiperspirant composition comprising reactive salts
US20230293400A1 (en) An Antiperspirant Composition
EP3223779B1 (en) Personal care composition with zinc phosphate active
US4490354A (en) Antiperspirant method containing vanadium salts
US5194249A (en) Non-whitening antiperspirant compositions
EP3941593B1 (en) An antiperspirant composition comprising reactive salts
US4219540A (en) Method for inhibiting perspiration
NZ199507A (en) Antiperspirant compositions containing an aluminium halohydrate and a stannic halide
JP2018203683A (en) Antiperspirant composition
US20220054374A1 (en) An antiperspirant composition comprising inorganic polyionic cluster